Income Statement
NEURAXIS, INC
NRXS
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Revenue
|
3.57 | 2.69 | 2.46 |
|
Cost of Revenue
|
0.56 | 0.36 | 0.30 |
|
Gross Profit
|
3.01 | 2.32 | 2.16 |
|
Operating Expenses
|
8.56 | 9.16 | 8.50 |
|
Research & Development
|
0.49 | 0.21 | 0.17 |
|
Selling, General & Administrative
|
8.06 | 8.95 | 8.33 |
|
Other Operating Expenses
|
- | - | - |
|
Operating Income
|
-5.55 | -6.83 | -6.34 |
|
Non-Operating Income
|
- | - | - |
|
Interest Income
|
- | - | - |
|
Interest Expense
|
0.07 | 0.17 | 0.48 |
|
Other Non-Op Income / Expense
|
0.03 | -1.08 | -7.96 |
|
Income Before Tax
|
- | - | - |
|
Income Tax Expense
|
- | - | - |
|
Non-Controlling Interest
|
- | - | - |
|
Net Income
|
-7.80 | -8.24 | -14.63 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - |
|
EBITDA
|
-5.49 | -6.79 | -6.30 |
|
Earnings Per Share (Basic)
|
-0.95 | -1.22 | -4.50 |
|
Diluted EPS
|
-0.95 | -1.22 | -4.50 |
|
Weighted Average Shares
|
9.08 | 6.92 | 3.25 |
|
Diluted Weighted Avg Shares
|
9.08 | 6.92 | 3.25 |
|
Comprehensive Income
|
- | - | - |